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Abstract 
Introduction: According to statistical data, the tendency towards an increase in the 
number of patients with keloid and hypertrophic scars at the site of skin lesions remains 
in the world, which in most cases is due to the lack of effective methods for preventing 
this type of complications. Therefore, the development of new methods of 
pharmacological correction, which allow us to normalize the wound healing process at 
an early stage, seems very relevant. One of the promising areas for the search for 
substances suitable for the prevention of pathological scars is the study of natural 
compounds possessing endothelioprotective activity, since, according to modern ideas, 
it is the endothelial dysfunction that underlies the pathogenesis of this complication. 
Materials and Methods: All studies were performed on 60 male rats of the Wistar line, 
divided into 6 experimental groups. New forms for external use based on flavonoids 
PMFI-92 and PMFI-93 and comparison preparations "Kontraktubeks", "Egallohit" were 
used as research objects. The effect of new PMFI-92 and PMFI-93 formulations on the 
vasodilating function of the endothelium of the skin of animals with chemical burn was 
introduced with the introduction of nitric oxide synthesis modifiers: acetylcholine 
(ACS), L-arginine, nitro-L-arginine methyl ester (L-NAME). The effect of local 
pharmacological support in this pathology on the level of endothelial (eNOS), neuronal 
(nNOS) and inducible (iNOS) nitric oxide syntheses was determined by the method of 
solid phase enzyme immunoassay (ELISA). 
Results and Discussion: Application of the proposed new forms based on natural 
compounds PMFI-92 and PMFI-93 allows to improve the vasodilating function of the 
endothelium already at the early stages of wound healing, with an increase in the 
concentration of eNOS and nNOS, as well as a decrease in the concentration of iNOS. 
Conclusion: The experimental data obtained by us testify to the pronounced positive 
effect of the local application of PMFI-93 and PMFI-92 compositions on the 
vasodilating function of the skin vessels, and also to restore the balance between the 
activities of various forms of nitric oxide synthases. 
Keywords: Endothelial dysfunction, keloid and hypertrophic scars, PMFI-92, PMFI-93, 
eNOS, nNOS, iNOS. 
 
Introduction 
Skin lesions leading to the formation of 
pathological scars are one of the main causes of 
aesthetic and functional defects in an average 
of 10-40% of patients [1, 2, 3]. In connection 
with the widespread prevalence of this 
problem, various scientific approaches have 
been developed that explain the pathogenesis of 
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the formation of pathological scars [4, 5, 6, 7, 
8, 9]. So, their formation is associated with a 
violation of microcirculation in the area of 
damage, with excessive intensity of 
inflammation, with the accumulation of excess 
collagen, etc. [4, 5, 6, 7, 8, 9]. In recent years, 
the greatest scientific interest is dysfunction of 
the endothelium of damaged vessels as a target 
of pharmacological action in the prevention of 
keloid and hypertrophic scars, since it is this 
pathological process that leads to a disruption 
in the metabolism of biologically active 
substances and mediators in the damaged 
surface [4, 5, 10]. In the modern 
pharmaceutical market, there are a number of 
drugs that affect these pathological 
mechanisms, with the exception of drugs 
capable of restoring the damaged endothelial 
function in the early stages of wound healing 
[4, 5, 11, 12, 13, 14]. So, to reduce the already 
formed shallow defect and prevent the 
formation of scars after uncomplicated damage, 
the gels Kontraktubeks and Egallohit use 
natural compounds [15, 16, 17, 18, 19]. At the 
same time, the search for ways of emergency 
prevention of the formation of a pathological 
scar is still relevant. In connection with the 
above, the creation of new forms for external 
application capable of restoring the endothelial 
function is very promising, and, in our opinion, 
it is expedient to consider natural compounds 
of the flavonoid series as objects for the 
creation of such preparations [4, 5, 20]. 
The purpose of this study was to study the 
effect of new forms for external use on the 
basis of the flavonoids PMFI-92 and PMFI-93 
on the vasodilating function of the endothelium 
as one of the components of the endothelial 
function, as well as the indirect determination 
of the activities of various isoforms of nitric 
oxide synthases, since restoring the balance 
between eNOS, nNOS and iNOS can act as one 
of the possible mechanisms for restoring both 
the vasodilating and endothelial functions in 
general. 
Materials and methods  
In the experiment, three-month-old male 
Wistar rats weighing 220-250 g were used, 
without external signs of diseases, divided into 
6 experimental groups of 10 animals each: 1 
group – pseudo-operated animals (L/O), 2 
group – negative control (NK), Group 3 – 
animals receiving the composition PMFI-92, 4 
group – PMFI-93, 5 group – comparison 
preparation "Kontraktubeks", 6 group – 
preparation of comparison "Egallohit". For 
narcosis, chloral hydrate was used, which was 
administered intraperitoneally at a dose of 350 
mg / kg, slaughter of animals was carried out 
under ether anesthesia. New forms for external 
use based on flavonoids PMFI-92 and PMFI-93 
and comparison preparations "Kontraktubeks", 
"Egallohit" were used as research objects. 
A chemical burn was modeled in rats on a 
pre-depilated area of the skin of the back by 
subcutaneous injection with 0.2 ml of glacial 
acetic acid. The investigated objects were 
applied to the damaged area of the skin 2 times 
a day for 1.0 g for 14 days, the registration of 
the indices was carried out on the 7th and 14th 
days of the experiment. The analysis of the 
vasodilating function of the endothelium was 
performed by ultrasound dopplerography with 
the intravenous administration of ASC (Sigma-
Aldrich, USA) at a dose of 0.1 mg / kg; L-
arginine (Sigma-Aldrich, USA) at a dose of 
150 mg/kg and nitro-L-arginine methyl ester 
(L-NAME) (Sigma-Aldrich, USA) at a dose of 
15 mg / kg [21]. The UZOP-010-01 sensor with 
an operating frequency of 25 MHz was located 
on the inside of the area of the skin of the 
rumen, the indices were recorded with the help 
of the MM-D-K-Minimax Doppler v.1.9 
working computer program. (Saint-Petersburg, 
Russia). ELISA was performed on a microtiter 
plate reader Tecan Infinite F50 (Austria) using 
species-specific nitric oxide synthetase assays 
of Cloud Clone Corp (USA). All studies 
corresponded to the rules of laboratory practice 
(GLP) in pre-clinical studies and the 
International Recommendations of the 
European Convention for the Protection of 
Vertebrates (1997). The results were processed 
using the variational statistics methods using 
the parametric t-test of the Student (t-test) and 
the nonparametric U-test (Mann-Whitney test) 
using the Statistica 6.0 and StatPlus 2009 
application packages, as well as Microsoft 
Office Excel 2007. 
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Results and Discussion  
The initial velocity of blood flow in the 
vessels of the skin of the back of the L/O 
animals was 2.366 ± 0.242 cm / sec, while in 
the NC animals on the 7th day of the 
experiment this index was significantly lower 
(p <0.001) 5.54 times compared to the first 
group , which is an unfavorable prognostic 
indicator [21]. It should be noted that local 
pharmacological stimulation of wound healing 
already at this stage of the experiment led to 
some improvement in the analyzed index, with 
the highest initial blood flow rate recorded in 
rats receiving the composition PMMI-93. In 
this group of rats, it was 0.606 ± 0.198 cm/sec, 
which exceeded the similar result in animals 
with pathology (p <0.05) by 1.42 times, and 
significantly exceeded by 1.17 times the same 
index in animals that received " Egallohit », in 
which the blood flow velocity in the zone of 
damage prior to the introduction of analyzers 
was 0.52 ± 0.089 cm/s. At the same time, in the 
animals of group 4, the initial blood flow 
velocity did not differ from that in the group 
receiving "Kontraktubeks" (0.6 ± 0.080 cm/s). 
In the rats receiving PMFI-92 during the week, 
the initial blood flow velocity was 0.57 ± 0.154 
cm/sec, which is 1.33 times higher than in the 
rats of group 1 (p<0.05), but was somewhat 
lower, than in animals, which during the week 
were applied PMFI-93 and Kontraktubeks. The 
results of the analysis of this indicator are 
clearly reflected in Figure 1. 
 
 
Fig. 1. Initial velocity of blood flow in the damaged area of the skin, cm/s 
Note: α – is statistically significant in relation to the group of pseudo-operated animals (p <0.001), 
single-factor analysis with the Bonferroni amendment 
 
An important diagnostic criterion for the 
state of the vasodilating function of the 
endothelium is the response of the vessels to 
intravenous administration of the ACX, which 
stimulates the production of nitric oxide and, 
accordingly, causes vasodilation [21]. Thus, in 
the animals of group 1, a classical response of 
the skin vessels to a given analyzer was 
observed, expressed in an increase in the 
average linear blood flow velocity by 47.61%  
(p <0.01) from its baseline level. Significantly 
less pronounced changes were recorded in 
group 2 – an increase in the blood flow velocity 
was only 8.14% of the baseline, which was 
5.84 times (p <0.05) lower than in rats and rats, 
and indirectly suggests prevalence of 
vasoconstriction over vasodilation. In contrast 
to the control group of rats with a rumen 
model, the response to the administration of the 
ACX is preserved in animals receiving the 
composition PMFI-93, as evidenced by an 
increase in blood flow velocity by 17.39% of 
the baseline (p <0.05), which is 2, 14 times 
higher than in NK animals. In addition, the 
blood flow velocity of this group of rats was 
significantly different from the group of the 
comparison drug "Kontraktubeks", where the 
blood flow velocity increased by 16.87% 
compared to its baseline level, and was 1.18 
times higher than in the group receiving
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«Egallohit» (+ 14.76% of the initial level). In 
response to the introduction of the ACS, the 
blood flow velocity in the group of animals 
receiving PMFI-92 increased by 17.62% (p 
<0.05) from its baseline, the index was 
significantly different from the ND and the 
groups of animals that received the comparator. 
Changes in the rate of cutaneous blood flow 
with intravenous administration of the ACS in 
all experimental groups are shown in Figure 2. 
 
Fig. 2. Increase in blood flow velocity with intravenous injection of acetylcholine 
Note: * – statistically significant with respect to the initial SC (p <0.05), ** – statistically significant 
with respect to the initial SC (p <0.01), γ – statistically significant in relation to the group of pseudo-
operated animals (p < 0.05), Δ – statistically significant in relation to the group of negative control 
animals (p <0.05), single-factor analysis with the Bonferroni amendment 
 
When L-arginine (substrate in the synthesis 
of nitric oxide synthesis) was administered to 
the animals of group No. 1, there were no 
significant changes in blood flow velocity, 
which agrees with available literature data [22]. 
A different reaction of the vessels to this 
analyzer was recorded in the group of NK rats, 
where the blood flow velocity increased by 
31.78% (p <0.05) relative to its baseline level, 
which is described in the literature as the  
"L-arginine paradox" phenomenon and is one 
of the important markers of disturbance of the 
vasodilating function [21, 22]. Already at this 
period of the experiment, it is possible to note 
the significant differences between the animals 
that received PMFI-92 and PMFI-93 in this 
indicator. Thus, the administration of L-
arginine to group No. 4 caused an unreliable 
increase in blood flow by only 8.06%, which is 
3.94 times lower (p <0.05) than in Group 2. In 
turn, when L-arginine was administered to 
group 3, the rate of cutaneous blood flow 
increased (in comparison with the initial value) 
by 12.35%, which was statistically significant 
(p <0.05) less than those in negative control 
groups in 2, 56 times. In animals that received 
the comparative drugs "Kontraktubeks" and 
"Egallohit", the analyzed index had 
significantly higher values (p <0.05) than in 
groups No.3, No.4: an increase was observed in 
comparison with the initial value against L-
arginine by 17.69% and 25.12% respectively 
(Fig. 3). 
Following the introduction of L-arginine 
blockade of the nitric oxide synthesis system by 
intravenous administration of L-NAME, the 
blood flow velocity in the damaged area of the 
skin in L / O animals decreased by 35.28% (p 
<0.05). At the same time, in rats with a model 
of a pathological scar, the blood flow rate 
decreased by only 6.75% from its baseline 
level. The lack of influence of L-NAME on the 
indicator under study may be due to the already 
existing deficiency in eNOS activity as a result 
of the simulated pathology and also supports 
the theory of the "L-arginine paradox" [21, 22]. 
The response of the vessels to L-NAME in all 
animals receiving PMFI-93 was more 
significant and was expressed in a decrease in 
the linear velocity of cutaneous blood flow: in 
rats with CEPR – by 16.29% (p <0.05), which 
was more than the same indicator in rats NK in
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2.41 times. Against the backdrop of L-NAME, 
a significant decrease (p <0.05) in the rate of 
cutaneous blood flow was observed in rats 
receiving the PMFI-92 composition at 16.12% 
of the baseline, which did not differ 
significantly from animals of the PMFI-93 
group. The use of comparator drugs led to a 
less pronounced vascular response (p <0.05): in 
the animals treated with Kontraktubeks, the 
blood flow rate decreased by 15.27%, and in 
rats that received Egallohit 14.50% its initial 
value (Fig. 4). 
 
 
 
Fig. 3. Increase in blood flow velocity with intravenous administration of L-arginine 
Note: * – statistically significant with respect to the initial SC (p <0.05), ** – statistically significant 
with respect to the initial SC (p <0.01), γ – statistically significant in relation to the group of pseudo-
operated animals (p < 0.05), Δ – statistically significant in relation to the group of negative control 
animals (p <0.05), single-factor analysis with the Bonferroni amendment 
 
 
Fig. 4. The drop in blood flow velocity with intravenous injection of L-NAME 
Note: * – statistically significant with respect to the initial SC (p <0.05), ** – statistically significant 
with respect to the initial SC (p <0.01), γ – statistically significant in relation to the group of pseudo-
operated animals (p < 0.05), Δ – statistically significant in relation to the group of negative control 
animals (p <0.05), single-factor analysis with the Bonferroni amendment 
 
Thus, it can be concluded that the chemical 
burn provoked a negative change in the 
vasodilating function of the vascular 
endothelium on the 7th day of the experiment, 
expressed in the weakening of the response to 
the administration of ACX and L-NAME and 
the enhancement of the response to L-arginine, 
while the local pharmacological the support of 
experimental compounds allowed to correct the 
described violations. At the same time, at the 
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current stage of the experiment, new forms of 
PMFI-93 and PMFI-92 became the leading 
objects. The results obtained during the 
analogous course of the experiment on day 14 
are presented in Table 1. 
Table 1 
Change in the rate of cutaneous blood flow with the introduction  
of analyzers 14 days after the reproduction of the pathology 
 
Group of 
animals 
Changes in blood flow velocity with the introduction  
of analyzers from the baseline, in % 
Increase Fall 
ATSX L-arginine L-NAME 
Group 1 47.61±0.711** 5.00±2.063 35.28±11.022* 
Group 2 8.55±1.631γ 22.73±5.673*γ 7.53±2.037γ 
Group 3 18.64±1.881*Δ 9.44±1.258Δ 17.67±2.005*Δ 
Group 4 19.49±2.746*Δ 7.89±2.375Δ 18.46±2.647*Δ 
Group 5 18.52±2.290 14.04±1.349Δ 17.30±2.088*Δ 
Group 6 15.53±1.660 17.78±10.278 15.77±1.653Δ 
Note: * – statistically significant with respect to the initial blood flow velocity (p <0.05), single-
factor analysis with Bonferroni correction; ** – statistically significant with respect to the initial blood 
flow velocity (p <0.01), single-factor analysis with Bonferroni correction; *** – statistically significant 
with respect to the initial blood flow velocity (p <0.001), single-factor analysis with Bonferroni 
correction; γ – statistically significant in relation to the group of pseudo-operated animals (p <0.05), 
single-factor variance analysis with Bonferroni amendment; Δ – statistically significant in relation to 
the group of negative control animals (p <0.05), single-factor analysis with the Bonferroni amendment; 
p is the level of the reliable difference. 
 
At this stage of the study, we can note the 
preservation of pathological changes in the 
group of rats # 1, as well as the presence of 
recovery dynamics when using local 
pharmacological support. At the same time, 
after analyzing all the indicators listed above on 
the 7th and 14th day of the experiment, the 
objects of investigation can be arranged in the 
following order, reflecting the increase in the 
effect on the vasodilating function of the 
endothelium: "Egallohit" <"Kontraktubeks" 
<"PMFI-92" <"PMFI-93" . 
Based on the well-known data that the 
process of improving the vasodilating function 
of the endothelium is primarily due to the 
restoration of the balance between the 
constitutive forms of eNOS, nNOS and the 
inducible form of iNOS, in the second stage of 
the studies we determined their concentration 
in the tissue homogenate of the damage zone 
on days 7 and 14 after the modeling of 
pathology [23, 24, 25, 26]. It was found that the 
compositions PMFI-93 and PMFI-92 are 
characterized by a unidirectional effect on 
vascular endothelial function, characterized by 
an increase in the concentration of constitutive 
NOS isoforms with a simultaneous decrease in 
iNOS content already on the 7th day of the 
experiment compared to animals not receiving 
pharmacological support. Thus, when PMFI-92 
was used in the indicated time interval, the 
concentrations of eNOS and nNOS were 
significantly higher than those in group No. 2, 
respectively, by 1.31 and 1.02 times, and when 
PMFI-93 was applied, 1.25 and 1 , 14 times. 
The concentration of the inducible form of the 
enzyme, in turn, decreased by 1.29 times in 
comparison with the NK animals. As for the 
comparison drug "Egallohit", it caused only a 
significant change in the concentration of 
eNOS, which was less pronounced than in 
groups Nos. 3 and 4. In animals that received 
the reference preparation "Kontraktubeks", a 
significant increase in eNOS activity was 
noted, and a decrease in iNOS activity in the 
PMFI-92 and PMFI-93 groups was observed. It 
should be emphasized that a similar trend is 
observed on the 14th day of the experiment 
(Table 2). 
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Table 2 
Determination of the concentrations of different isoforms of nitric oxide synthases at 7 and 14 days of the experiment 
 
NOS 
Concentration 
Group 1 
Group 2 Group 3 Group 4 Group 5 Group 6 
7 days 14 days 7 days 14 days 7days 14 days 7 days 14 days 7 days 14 days 
eNOS, 
ng/ml 
97.33±2.5
77 
76.80±0.61
5
#
 
73.94±3.07
1
#
 
100.45±1.0
04
▲
 
264.69±9.96
4
▲
 
96.34±0.6
95
▲
 
126.58±5.5
81
▲
 
93.74±0.94
7
▲
 
98.98±1.11
6
▲
 
84.56±1.4
61
▲
 
84.99±2.7
15
▲
 
nNOS, 
ng/ml 
17.71± 
2.329 
31.77± 
0.997
#
 
26.97± 
0.389
#
 
32.27± 
9.187
▲
 
43.58± 
8.616
▲
 
36.28± 
6.149
▲
 
39.46± 
3.192
▲
 
27.03± 
3.564 
24.93± 
0.240 
31.61± 
5.010 
21.78± 
5.539 
iNOSin 
plasma, 
ng/ml 
14.16± 
0.448 
31.89± 
4.587
#
 
30.31± 
1.986
#
 
24.79± 
1.672
▲
 
24.03± 
2.857
▲
 
24.78± 
4.299 
24.75± 
3.566
▲
 
21.88± 
4.259
▲
 
22.05± 
2.347
▲
 
35.64± 
2.503 
36.20± 
4.977 
 
Note: # – statistically significant in relation to the group of pseudo-operated animals (p <0.05), U – Mann-Whitney test; ▲ – statistically significant in 
relation to the negative control group (p <0.05), U – Mann-Whitney test. 
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Conclusion 
Thus, the selected model of the 
pathological scar is accompanied by a 
persistent violation of the vasodilating function 
of the endothelium, as evidenced by the change 
in the response of the vessels of the skin to the 
administration of the ACS, L-NAME, L-
arginine. In this group of animals there was a 
decrease in the concentration of eNOS with a 
simultaneous increase in the content of iNOS. 
Using PMFI-93 and PMFI-92 formulations on 
the basis of natural compounds, early in wound 
healing (7th day), it is possible to improve 
vasodilation and endothelial function, which is 
important for the prevention of the formation of 
pathological scars. In this case, the 
normalization of the vasodilatation process may 
be related to the enhancement of eNOS 
activity, and also to the inhibition of iNOS 
under the action of the listed formulations. The 
results of this study indicate the prospects of 
these compounds for further deeper study with 
the goal of creating on their basis an external 
dosage form with endothelioprotective activity 
for preventing the formation of pathological 
scars. 
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